The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men

International Journal of Andrology

Volumn 26, Issue 3, 2003, Pages 187-194

  Härkönen, Kati ^a,d   Huhtaniemi, Ilpo ^a   Mäkinen, Juha ^a   Hübler, Doris ^c   Irjala, Kerttu ^a   Koskenvuo, Markku ^a   Oettel, Michael ^c   Raitakari, Olli ^b   Saad, Farid ^c   Pöllänen, Pasi ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c BAYER PHARMA AG   (Germany)

^d NONE   (Finland)

Author keywords

Ageing male; Androgen receptor; Andropause; CAG repeat; Depression; Partial androgen deficiency of the ageing male (PADAM); Polymorphism; Potency

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CAGA PROTEIN; ESTRADIOL; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; AGING; ARTICLE; BLOOD DONOR; DEPRESSION; DNA POLYMORPHISM; ESTRADIOL BLOOD LEVEL; GENE AMPLIFICATION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS TESTIS SYSTEM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NUCLEOTIDE REPEAT; POLYMERASE CHAIN REACTION; POTENCY DISORDER; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; AGING; ANDROGENS; CLIMACTERIC; HUMANS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PITUITARY GLAND; RECEPTORS, ANDROGEN; TESTIS; TESTOSTERONE; TRINUCLEOTIDE REPEATS;

EID: 0038460127     PISSN: 01056263     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2605.2003.00415.x     Document Type: Article

References (54)

1. Anderson, D. C., Thorner, M. O., Fisher, R. A., Woodham, J. P., Goble, H. L. & Besser, G. M. (1975) Effects of hormonal treatment on plasma unbound androgen levels in hirsute women. 10th Acta Endocrinologica Congress. Acta Endocrinologica (Kbh) Suppl. 199, 224 (Abstract, 159).
2. Arbizu, T., Santamaria, J., Gomez, J. M., Quilez, A. & Serra, J. P. (1983) A family with adult spinal and bulbar muscular atrophy, X-linked inheritance and associated testicular failure. Journal of the Neurological Sciences 59, 371-382.
3. Balic, I., Graham, S. T., Troyer, D. A., Higgins, B. A., Pollock, B. H., Johnson-Pais, T. L., Thompson, I. M. & Leach, R. J. (2002) Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men. Journal of Urology 168, 2245-2248.
4. Barrett-Connor, E., Von Muhlen, D. G. & Kritz-Silverstein, D. (1999) Bioavailable testosterone and depressed mood in older men: the Rancho Bemardo Study. Journal of Clinical Endocrinology and Metabolism 84, 573-577.
5. Beilin, J., Ball, E. M. A., Favaloro, J. M. & Zajac, J. D. (2000) Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. Journal of Molecular Endocrinology 25, 85-96.
6. Calvo, R. M., Asuncion, M., Sancho, J., San Millan, J. L. & Escobar-Morreale, H. F. (2000) The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. Journal of Clinical Endocrinology and Metabolism 85, 1735-1740.
7. Chamberlain, N. L., Driver, E. D. & Miesfeld, P. L. (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Research 22, 3181-3186.
8. Comhaire, F. H. (2000) Andropause: hormone replacement therapyin the ageing male. European Urology 38, 655-662.
9. Deplewski, D. & Rosenfield, R. L. (2000) Role of hormones in pilosebaceous unit development. Endocrine Reviews 21, 363-392.
10. Deslypere, J. P., Kaufman, J. M., Vermeulen, T., Vogelaers, D., Vandalem, J. L. & Vermeulen, A. (1987) Influence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in men. Journal of Clinical Endocrinology and Metabolism 64, 68-73.
11. Dowsing, A. T., Yong, E. L., Clark, M., McLachlan, R. I., de Kretser, D. M. & Trounson, A. O. (1999) Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene. Lancet 354, 640-643.
12. Edwards, A., Hammond, H. A., Jin, L., Caskey, T. & Chakraborty, R. (1992) Genetic variation in five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics 12, 241-253.
13. Ehrenreich, H., Halaris, A., Ruether, E., Hufner, M., Funke, M. & Kunert, H. J. (1999) Psychoendocrine sequelae of chronic testosterone deficiency. Journal of Psychiatric Research 33, 379-387.
14. Giovannucci, E., Platz, E. A., Stampfer, M. J., Chan, A., Krithivas, K., Kawachi, I., Willett, W. C. & Kantoff, P. W. (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology 53, 121-125.
15. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Dahl, D., Brufsky, A., Talcott, J., Hennekens, C. H. & Kantoff, P. W. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 94, 3320-3323.
16. Gray, A., Feldman, H. A., McKinlay, J. B. & Longcope, C. (1991) Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. Journal of Clinical Endocrinology and Metabolism 73, 1016-1025.
17. Grinspoon, S., Corcoran, C., Stanley, T., Baaj, A., Basgoz, N. & Klibanski, A. (2000) Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. Journal of Clinical Endocrinology and Metabolism 85, 60-65.
18. Hakimi, J. M., Schoenberg, M. P., Rondinelli, R. H., Piantadosi, S. & Barrack, E. R. (1997) Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clinical Cancer Research 3, 1599-1608.
19. Hallberg, M. C., Wieland, R. G., Zorn, E. M., Furst, B. H. & Wieland, J. M. (1976) Impaired Leydig cell reserve and altered serum androgen binding in the aging male. Fertility and Sterility 27, 812-814.
20. Hardy, D. O., Scher, H. I., Bogenreider, T., Sabbatini, P., Zhang, Z. F., Nanus, D. M. & Catterall, J. F. (1996) Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. Journal of Clinical Endocrinology and Metabolism 81, 4400-4405.
21. Heinemann, L. A. J., Zimmermann, T., Vermeulen, A., Thiel, C. & Hummel, W. (1999) A new aging male's symptoms' rating scale. The Aging Male 2, 105-114.
22. Hsiao, P. W., Lin, D. L., Nakao, R. & Chang, C. (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. The Journal of Biological Chemistry 274, 20 229-20 234.
23. Hsing, A. W., Gao, Y. T., Wu, G., Wang, X., Deng, J., Chen, Y. L., Sesterhenn, I. A., Mostofi, F. K., Benichou, J. & Chang, C. (2000) Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Research 60, 5111-5116.
24. Ingles, S. A., Ross, R. K., Yu M. C., Irvine, R. A., La Pera, G., Halle, R. W. & Coetzee, G. A. (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. Journal of the National Cancer Institute 89, 166-170.
25. Irvine, R. A., Yu M. C., Ross, R. K. & Coetzee, G. A. (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Research 54, 1936-1940.
26. Irvine, R. A. & Ma, H., Yu, M. C., Ross, R. K., Stallcup, M. R. & Coetzee, G. A. (2000) Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Human Molecular Genetics 9, 267-274.
27. Jenster, G., de Ruiter, P. E., van der Korput, H. A., Kuiper, G. G., Trapman, J. & Brinkmann, A. O. (1994) Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry 33, 14 064-14 072.
28. Kaiser, F. E., Viosca, S. P., Morley, J. E., Mooradian, A. D., Davis, S. S. & Korenman, S. G. (1988) Impotence and aging: clinical and hormonal factors. Journal of the American Geriatrics Society 36, 511-519.
29. Kaufman, J. M., Deslypere, J. P., Giri, M. & Vermeulen, A. (1990) Neuroendocrine regulation of pulsatile luteinizing hormone secretion in elderly men. The Journal of Steroid Biochemistry and Molecular Biology 37, 421-430.
30. Kazemi-Esfarjani, P., Trifiro, M. A. & Pinsky, L. (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Human Molecular Genetics 4, 523-527.
31. Koivumaa-Honkanen, H., Honkanen, R., Viinamäki, H., Heikkilä, K., Kaprio, J. & Koskenvuo, M. (2000) Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. American Journal of Epidemiology 152, 983-991.
32. Korenman, S. G., Morley, J. E., Mooradian, A. D., Davis, S. S., Kaiser, F. E., Silver, A. J., Viosca, S. P. & Garza, D. (1990) Secondary hypogonadism in older men: its relation to impotence. Journal of Clinical Endocrinology and Metabolism 71, 963-969.
33. Krithivas, K., Yurgalevitch, S. M., Mohr, B. A., Wilcox, C. J., Batter, S. J., Brown, M., Longcope, C., McKinlay, J. B. & Kantoff, P. W. (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. Journal of Endocrinology 162, 137-142.
34. La Spada, A. R., Wilson, E. M., Lubahn, D. B., Harding, A. E. & Fischbeck, K. H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77-79.
35. Legro, R. S., Shahbahrami, B., Lobo, R. A. & Kovacs, B. W. (1994) Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgemc characteristics. Obstetrics and Gynecology 83, 701-706.
36. Lund, A., Udd, B., Juvonen, V., Andersen, P. M., Cederquist, K., Ronnevi, L. O. et al. (2000) Founder effect in spinal and bulbar muscular atrophy (SBMA) in Scandinavia. European Journal of Human Genetics 8, 631-636.
37. Mhatre, A. N., Trifiro, M. A., Kaufman, M., Kazemi-Esfarjani, P., Figlewicz, D., Rouleau, G. & Pinsky, L. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 5, 184-188.
38. Mifsud, A., Sim, C. K., Boettger-Tong, H., Moreira, S., Lamb, D. J., Lipshultz, L. I. & Yong, E. L. (2001) Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility. Fertility and Sterility 75, 275-281.
39. Morley, J. E., Kaiser, F. E., Perry, H. M. 3rd, Patrick, P., Morley, P. M., Stauber, P. M., Vellas, B., Baumgartner, R. N. & Garry, P. J. (1997) Longitudinal changes in testosterone, luteinizing hormone, and follicle stimulating hormone in healthy older men. Metabolism 46, 410-413.
40. Morley, J. E. & Perry, H. M. 3rd (2000) Androgen deficiency in aging men: role of testosterone replacement therapy. Journal of Laboratory and Clinical Medicine 135, 370-378.
41. Nagashima, T., Seko, K., Hirose, K., Mannen, T., Yoshimura, S., Arima, R., Nagashima, K. & Mofimatsu, Y. (1988) Familial bulbo-spinal muscular atrophy associated with testicular atrophy and sensory neuropathy (Kennedy-Alter-Sung syndrome). Autopsy case report of two brothers. Journal of the Neurological Sciences 87, 141-152.
42. Nakajima, H., Kimura, F., Nakagawa, T., Furutama, D., Shinoda, K., Shimizu, A. & Ohsawa, N. (1996) Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy. Journal of the Neurological Sciences 142, 12-16.
43. Platz, E. A., Rimm, E. B., Willett, W. C., Kantoff, P. W. & Giovannucci, E. (2000) Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. Journal of the National Cancer Institute 92, 2009-2017.
44. Sawaya, M. E. & Shalita, A. R. (1998) Androgen receptor polymorphisms (CAG repeat lengths) in androgenedc alopecia, hirsutism, and acne. Journal of Cutaneous Medicine and Surgery 3, 9-15.
45. Seidman, S. N. & Rabkin, J. G. (1998) Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression. Journal of Affective Disorders 48, 157-161.
46. Seidman, S. N., Spatz, E., Rizzo, C. & Roose, S. P. (2001a) Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. Journal of Clinical Psychiatry 62, 406-412.
47. Seidman, S. N., Araujo, A. B., Roose, S. P. & McKinlay, J. B. (2001b) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men, Biological Psychiatry 50, 371-376.
48. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S. et al. (2000) Expanded polyglutamine stretches interact with TAFII130, interfering with CKEB-dependent transcription. Nature Genetics 26, 29-36.
49. Tennekoon, K. H. & Karunanayake, E. H. (1993) Serum FSH, LH, and testosterone concentrations in presumably fertile men: effect of age. International Journal of Fertility 38, 108-112.
50. Tut, T. G., Ghadessy, F. J., Trifiro, M. A., Pinsky, L. & Yong, E. L. (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility. Journal of Clinical Endocrinology and Metabolism 82, 3777-3782.
51. Vermeulen, A. (2000) Andropause. Maturitas 34, 5-15.
52. Vermeulen, A., Deslypere, J. P. & De Meirleir, K. (1989) A new look to the andropause: altered function of the gonadotrophs. Journal of Steroid Biochemistry 32, 163-165.
53. Vottero, A., Stratakis, C. A., Ghizzoni, L., Longui, C. A., Karl, M. & Chrousos, G. P. (1999) Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. Journal of Clinical Endocrinology and Metabolism 84, 1091-1095.
54. Yesavage, J. A., Davidson, J., Widrow, L. & Berger, P. A. (1985) Plasma testosterone levels, depression, sexuality, and age. Biological Psychiatry 20, 222-225.